Global Haemophilus Influenzae Type b Conjugate Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Haemophilus Influenzae Type b Conjugate Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Haemophilus Influenzae Type b Conjugate Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Haemophilus Influenzae Type b Conjugate Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Haemophilus Influenzae Type b Conjugate Vaccine Segment by Type

2.2.1 Vials

2.2.2 Prefilled

2.3 Haemophilus Influenzae Type b Conjugate Vaccine Sales by Type

2.3.1 Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Haemophilus Influenzae Type b Conjugate Vaccine Sale Price by Type (2017-2022)

2.4 Haemophilus Influenzae Type b Conjugate Vaccine Segment by Application

2.4.1 Hospitals

2.4.2 Community Health Service Center

2.4.3 Others

2.5 Haemophilus Influenzae Type b Conjugate Vaccine Sales by Application

2.5.1 Global Haemophilus Influenzae Type b Conjugate Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Haemophilus Influenzae Type b Conjugate Vaccine Sale Price by Application (2017-2022)

3 Global Haemophilus Influenzae Type b Conjugate Vaccine by Company

3.1 Global Haemophilus Influenzae Type b Conjugate Vaccine Breakdown Data by Company

3.1.1 Global Haemophilus Influenzae Type b Conjugate Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Haemophilus Influenzae Type b Conjugate Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Company (2020-2022)

3.2.2 Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Haemophilus Influenzae Type b Conjugate Vaccine Sale Price by Company

3.4 Key Manufacturers Haemophilus Influenzae Type b Conjugate Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Haemophilus Influenzae Type b Conjugate Vaccine Product Location Distribution

3.4.2 Players Haemophilus Influenzae Type b Conjugate Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Haemophilus Influenzae Type b Conjugate Vaccine by Geographic Region

4.1 World Historic Haemophilus Influenzae Type b Conjugate Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Haemophilus Influenzae Type b Conjugate Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Haemophilus Influenzae Type b Conjugate Vaccine Annual Revenue by Geographic Region

4.2 World Historic Haemophilus Influenzae Type b Conjugate Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Haemophilus Influenzae Type b Conjugate Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Haemophilus Influenzae Type b Conjugate Vaccine Annual Revenue by Country/Region

4.3 Americas Haemophilus Influenzae Type b Conjugate Vaccine Sales Growth

4.4 APAC Haemophilus Influenzae Type b Conjugate Vaccine Sales Growth

4.5 Europe Haemophilus Influenzae Type b Conjugate Vaccine Sales Growth

4.6 Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Sales Growth

5 Americas

5.1 Americas Haemophilus Influenzae Type b Conjugate Vaccine Sales by Country

5.1.1 Americas Haemophilus Influenzae Type b Conjugate Vaccine Sales by Country (2017-2022)

5.1.2 Americas Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Country (2017-2022)

5.2 Americas Haemophilus Influenzae Type b Conjugate Vaccine Sales by Type

5.3 Americas Haemophilus Influenzae Type b Conjugate Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Haemophilus Influenzae Type b Conjugate Vaccine Sales by Region

6.1.1 APAC Haemophilus Influenzae Type b Conjugate Vaccine Sales by Region (2017-2022)

6.1.2 APAC Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Region (2017-2022)

6.2 APAC Haemophilus Influenzae Type b Conjugate Vaccine Sales by Type

6.3 APAC Haemophilus Influenzae Type b Conjugate Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Haemophilus Influenzae Type b Conjugate Vaccine by Country

7.1.1 Europe Haemophilus Influenzae Type b Conjugate Vaccine Sales by Country (2017-2022)

7.1.2 Europe Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Country (2017-2022)

7.2 Europe Haemophilus Influenzae Type b Conjugate Vaccine Sales by Type

7.3 Europe Haemophilus Influenzae Type b Conjugate Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine by Country

8.1.1 Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Sales by Type

8.3 Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Haemophilus Influenzae Type b Conjugate Vaccine

10.3 Manufacturing Process Analysis of Haemophilus Influenzae Type b Conjugate Vaccine

10.4 Industry Chain Structure of Haemophilus Influenzae Type b Conjugate Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Haemophilus Influenzae Type b Conjugate Vaccine Distributors

11.3 Haemophilus Influenzae Type b Conjugate Vaccine Customer

12 World Forecast Review for Haemophilus Influenzae Type b Conjugate Vaccine by Geographic Region

12.1 Global Haemophilus Influenzae Type b Conjugate Vaccine Market Size Forecast by Region

12.1.1 Global Haemophilus Influenzae Type b Conjugate Vaccine Forecast by Region (2023-2028)

12.1.2 Global Haemophilus Influenzae Type b Conjugate Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Haemophilus Influenzae Type b Conjugate Vaccine Forecast by Type

12.7 Global Haemophilus Influenzae Type b Conjugate Vaccine Forecast by Application

13 Key Players Analysis

13.1 Bharat Biotech

13.1.1 Bharat Biotech Company Information

13.1.2 Bharat Biotech Haemophilus Influenzae Type b Conjugate Vaccine Product Offered

13.1.3 Bharat Biotech Haemophilus Influenzae Type b Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bharat Biotech Main Business Overview

13.1.5 Bharat Biotech Latest Developments

13.2 Glaxosmithkline

13.2.1 Glaxosmithkline Company Information

13.2.2 Glaxosmithkline Haemophilus Influenzae Type b Conjugate Vaccine Product Offered

13.2.3 Glaxosmithkline Haemophilus Influenzae Type b Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Glaxosmithkline Main Business Overview

13.2.5 Glaxosmithkline Latest Developments

13.3 Biokangtai

13.3.1 Biokangtai Company Information

13.3.2 Biokangtai Haemophilus Influenzae Type b Conjugate Vaccine Product Offered

13.3.3 Biokangtai Haemophilus Influenzae Type b Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Biokangtai Main Business Overview

13.3.5 Biokangtai Latest Developments

13.4 Lanzhou Institute

13.4.1 Lanzhou Institute Company Information

13.4.2 Lanzhou Institute Haemophilus Influenzae Type b Conjugate Vaccine Product Offered

13.4.3 Lanzhou Institute Haemophilus Influenzae Type b Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Lanzhou Institute Main Business Overview

13.4.5 Lanzhou Institute Latest Developments

13.5 Olymvax

13.5.1 Olymvax Company Information

13.5.2 Olymvax Haemophilus Influenzae Type b Conjugate Vaccine Product Offered

13.5.3 Olymvax Haemophilus Influenzae Type b Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Olymvax Main Business Overview

13.5.5 Olymvax Latest Developments

13.6 Sanofi Pasteur

13.6.1 Sanofi Pasteur Company Information

13.6.2 Sanofi Pasteur Haemophilus Influenzae Type b Conjugate Vaccine Product Offered

13.6.3 Sanofi Pasteur Haemophilus Influenzae Type b Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Sanofi Pasteur Main Business Overview

13.6.5 Sanofi Pasteur Latest Developments

13.7 Walvax Biotechnology

13.7.1 Walvax Biotechnology Company Information

13.7.2 Walvax Biotechnology Haemophilus Influenzae Type b Conjugate Vaccine Product Offered

13.7.3 Walvax Biotechnology Haemophilus Influenzae Type b Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Walvax Biotechnology Main Business Overview

13.7.5 Walvax Biotechnology Latest Developments

13.8 Zhifei Biological

13.8.1 Zhifei Biological Company Information

13.8.2 Zhifei Biological Haemophilus Influenzae Type b Conjugate Vaccine Product Offered

13.8.3 Zhifei Biological Haemophilus Influenzae Type b Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Zhifei Biological Main Business Overview

13.8.5 Zhifei Biological Latest Developments

14 Research Findings and Conclusion

Table 1. Haemophilus Influenzae Type b Conjugate Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Haemophilus Influenzae Type b Conjugate Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Vials

Table 4. Major Players of Prefilled

Table 5. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales by Type (2017-2022) & (K Units)

Table 6. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Type (2017-2022)

Table 7. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Type (2017-2022)

Table 9. Global Haemophilus Influenzae Type b Conjugate Vaccine Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales by Application (2017-2022) & (K Units)

Table 11. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Application (2017-2022)

Table 12. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Application (2017-2022)

Table 13. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Application (2017-2022)

Table 14. Global Haemophilus Influenzae Type b Conjugate Vaccine Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales by Company (2020-2022) & (K Units)

Table 16. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Company (2020-2022)

Table 17. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Company (2020-2022)

Table 19. Global Haemophilus Influenzae Type b Conjugate Vaccine Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Haemophilus Influenzae Type b Conjugate Vaccine Producing Area Distribution and Sales Area

Table 21. Players Haemophilus Influenzae Type b Conjugate Vaccine Products Offered

Table 22. Haemophilus Influenzae Type b Conjugate Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Haemophilus Influenzae Type b Conjugate Vaccine Sales by Country (2017-2022) & (K Units)

Table 34. Americas Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Country (2017-2022)

Table 35. Americas Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Country (2017-2022)

Table 37. Americas Haemophilus Influenzae Type b Conjugate Vaccine Sales by Type (2017-2022) & (K Units)

Table 38. Americas Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Type (2017-2022)

Table 39. Americas Haemophilus Influenzae Type b Conjugate Vaccine Sales by Application (2017-2022) & (K Units)

Table 40. Americas Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Application (2017-2022)

Table 41. APAC Haemophilus Influenzae Type b Conjugate Vaccine Sales by Region (2017-2022) & (K Units)

Table 42. APAC Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Region (2017-2022)

Table 43. APAC Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Region (2017-2022)

Table 45. APAC Haemophilus Influenzae Type b Conjugate Vaccine Sales by Type (2017-2022) & (K Units)

Table 46. APAC Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Type (2017-2022)

Table 47. APAC Haemophilus Influenzae Type b Conjugate Vaccine Sales by Application (2017-2022) & (K Units)

Table 48. APAC Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Application (2017-2022)

Table 49. Europe Haemophilus Influenzae Type b Conjugate Vaccine Sales by Country (2017-2022) & (K Units)

Table 50. Europe Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Country (2017-2022)

Table 51. Europe Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Country (2017-2022)

Table 53. Europe Haemophilus Influenzae Type b Conjugate Vaccine Sales by Type (2017-2022) & (K Units)

Table 54. Europe Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Type (2017-2022)

Table 55. Europe Haemophilus Influenzae Type b Conjugate Vaccine Sales by Application (2017-2022) & (K Units)

Table 56. Europe Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Haemophilus Influenzae Type b Conjugate Vaccine

Table 66. Key Market Challenges & Risks of Haemophilus Influenzae Type b Conjugate Vaccine

Table 67. Key Industry Trends of Haemophilus Influenzae Type b Conjugate Vaccine

Table 68. Haemophilus Influenzae Type b Conjugate Vaccine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Haemophilus Influenzae Type b Conjugate Vaccine Distributors List

Table 71. Haemophilus Influenzae Type b Conjugate Vaccine Customer List

Table 72. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Forecast by Region

Table 74. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Haemophilus Influenzae Type b Conjugate Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Haemophilus Influenzae Type b Conjugate Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Haemophilus Influenzae Type b Conjugate Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Haemophilus Influenzae Type b Conjugate Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Haemophilus Influenzae Type b Conjugate Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Haemophilus Influenzae Type b Conjugate Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Bharat Biotech Basic Information, Haemophilus Influenzae Type b Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. Bharat Biotech Haemophilus Influenzae Type b Conjugate Vaccine Product Offered

Table 94. Bharat Biotech Haemophilus Influenzae Type b Conjugate Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Bharat Biotech Main Business

Table 96. Bharat Biotech Latest Developments

Table 97. Glaxosmithkline Basic Information, Haemophilus Influenzae Type b Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. Glaxosmithkline Haemophilus Influenzae Type b Conjugate Vaccine Product Offered

Table 99. Glaxosmithkline Haemophilus Influenzae Type b Conjugate Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Glaxosmithkline Main Business

Table 101. Glaxosmithkline Latest Developments

Table 102. Biokangtai Basic Information, Haemophilus Influenzae Type b Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. Biokangtai Haemophilus Influenzae Type b Conjugate Vaccine Product Offered

Table 104. Biokangtai Haemophilus Influenzae Type b Conjugate Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Biokangtai Main Business

Table 106. Biokangtai Latest Developments

Table 107. Lanzhou Institute Basic Information, Haemophilus Influenzae Type b Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 108. Lanzhou Institute Haemophilus Influenzae Type b Conjugate Vaccine Product Offered

Table 109. Lanzhou Institute Haemophilus Influenzae Type b Conjugate Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Lanzhou Institute Main Business

Table 111. Lanzhou Institute Latest Developments

Table 112. Olymvax Basic Information, Haemophilus Influenzae Type b Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 113. Olymvax Haemophilus Influenzae Type b Conjugate Vaccine Product Offered

Table 114. Olymvax Haemophilus Influenzae Type b Conjugate Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Olymvax Main Business

Table 116. Olymvax Latest Developments

Table 117. Sanofi Pasteur Basic Information, Haemophilus Influenzae Type b Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 118. Sanofi Pasteur Haemophilus Influenzae Type b Conjugate Vaccine Product Offered

Table 119. Sanofi Pasteur Haemophilus Influenzae Type b Conjugate Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Sanofi Pasteur Main Business

Table 121. Sanofi Pasteur Latest Developments

Table 122. Walvax Biotechnology Basic Information, Haemophilus Influenzae Type b Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 123. Walvax Biotechnology Haemophilus Influenzae Type b Conjugate Vaccine Product Offered

Table 124. Walvax Biotechnology Haemophilus Influenzae Type b Conjugate Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Walvax Biotechnology Main Business

Table 126. Walvax Biotechnology Latest Developments

Table 127. Zhifei Biological Basic Information, Haemophilus Influenzae Type b Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 128. Zhifei Biological Haemophilus Influenzae Type b Conjugate Vaccine Product Offered

Table 129. Zhifei Biological Haemophilus Influenzae Type b Conjugate Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Zhifei Biological Main Business

Table 131. Zhifei Biological Latest Developments

List of Figures

Figure 1. Picture of Haemophilus Influenzae Type b Conjugate Vaccine

Figure 2. Haemophilus Influenzae Type b Conjugate Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Haemophilus Influenzae Type b Conjugate Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Vials

Figure 10. Product Picture of Prefilled

Figure 11. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Type in 2021

Figure 12. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Type (2017-2022)

Figure 13. Haemophilus Influenzae Type b Conjugate Vaccine Consumed in Hospitals

Figure 14. Global Haemophilus Influenzae Type b Conjugate Vaccine Market: Hospitals (2017-2022) & (K Units)

Figure 15. Haemophilus Influenzae Type b Conjugate Vaccine Consumed in Community Health Service Center

Figure 16. Global Haemophilus Influenzae Type b Conjugate Vaccine Market: Community Health Service Center (2017-2022) & (K Units)

Figure 17. Haemophilus Influenzae Type b Conjugate Vaccine Consumed in Others

Figure 18. Global Haemophilus Influenzae Type b Conjugate Vaccine Market: Others (2017-2022) & (K Units)

Figure 19. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Application (2017-2022)

Figure 20. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Application in 2021

Figure 21. Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Company in 2021

Figure 23. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Geographic Region in 2021

Figure 25. Global Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Region (2017-2022)

Figure 26. Global Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Country/Region in 2021

Figure 27. Americas Haemophilus Influenzae Type b Conjugate Vaccine Sales 2017-2022 (K Units)

Figure 28. Americas Haemophilus Influenzae Type b Conjugate Vaccine Revenue 2017-2022 ($ Millions)

Figure 29. APAC Haemophilus Influenzae Type b Conjugate Vaccine Sales 2017-2022 (K Units)

Figure 30. APAC Haemophilus Influenzae Type b Conjugate Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. Europe Haemophilus Influenzae Type b Conjugate Vaccine Sales 2017-2022 (K Units)

Figure 32. Europe Haemophilus Influenzae Type b Conjugate Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Revenue 2017-2022 ($ Millions)

Figure 35. Americas Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Country in 2021

Figure 36. Americas Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Country in 2021

Figure 37. United States Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Region in 2021

Figure 42. APAC Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Regions in 2021

Figure 43. China Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Country in 2021

Figure 50. Europe Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Country in 2021

Figure 51. Germany Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Haemophilus Influenzae Type b Conjugate Vaccine Revenue Market Share by Country in 2021

Figure 58. Egypt Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Haemophilus Influenzae Type b Conjugate Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Haemophilus Influenzae Type b Conjugate Vaccine in 2021

Figure 64. Manufacturing Process Analysis of Haemophilus Influenzae Type b Conjugate Vaccine

Figure 65. Industry Chain Structure of Haemophilus Influenzae Type b Conjugate Vaccine

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles